ARCHIVES

In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

In Brief: BRCA 2 Gene sequence Published; CALGB To Mark 40th Anniversary

March 8, 1996

In Brief: ONS, ASCO AACR Meetings Open In St. Louis Next Week; Bristol-Myers Adds Farber, McArdle Grants

April 16, 1982

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003

Conte To Introduce Bill To Stem Loss Of NIH “Superstars”

March 31, 1989